Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination. - Wikidata - awgldk - TriplyDB

Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination.

Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination.

http://www.wikidata.org/entity/Q34075698

about

Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedles Papilloma-pseudovirus eradicates intestinal tumours and triples the lifespan of ApcMin/+ mice.Topical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challenge Aerosol delivery of virus-like particles to the genital tract induces local and systemic antibody responses.Antibody to the gp120 V1/V2 loops and CD4+ and CD8+ T cell responses in protection from SIVmac251 vaginal acquisition and persistent viremia.Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine.Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA.Replicating adenovirus-simian immunodeficiency virus (SIV) vectors efficiently prime SIV-specific systemic and mucosal immune responses by targeting myeloid dendritic cells and persisting in rectal macrophages, regardless of immunization route.Zinc finger arrays binding human papillomavirus types 16 and 18 genomic DNA: precursors of gene-therapeutics for in-situ reversal of associated cervical neoplasia Human papillomavirus capsids preferentially bind and infect tumor cells.Intravaginal immunization with HPV vectors induces tissue-resident CD8+ T cell responses.Immunogenic Human Papillomavirus Pseudovirus-Mediated Suicide-Gene Therapy for Bladder Cancer.Genital delivery of virus-like particle and pseudovirus-based vaccines Virus-like particles for the prevention of human papillomavirus-associated malignancies.HPV pseudovirions as DNA delivery vehicles.Viruslike Particles Encapsidating Respiratory Syncytial Virus M and M2 Proteins Induce Robust T Cell Responses.Non-human papillomaviruses for gene delivery in vitro and in vivo.Respiratory syncytial virus vaccine development

P2860

Q27311290-048396F6-1DF9-4511-AECE-B21980F0BF05 Q33571959-3FEAC8B7-1F58-4FBA-9533-5A6CD23E8B14 Q34992660-AF4F84DF-96F0-4EA3-8B6B-D777B391BD2C Q35042602-123AE0B6-05AB-4E11-B3FF-49B8D2952B03 Q35105449-C973079C-E465-4A53-9503-566FEBF9704F Q35112676-877DEC4D-BC58-49F5-8BA0-879D143E1052 Q35658952-F4557475-A196-4B95-B004-2D42A59272CD Q35940685-2EC835FD-F2C6-471B-8E95-5595062AC8A6 Q36437222-F6245536-3AE6-4217-ABB2-37ED7A96DF6D Q36470809-2902C721-197F-4E46-BA3A-1912FB31A6B0 Q36498016-52B1AF71-1D90-4D40-8598-F9BA7A57CFF4 Q37134623-D96CC594-C1E3-4EFF-8D7F-0E982B088A9B Q37205981-2B9D9B52-8744-411B-8EA9-6D00223E98E4 Q37328475-15712010-9FCC-4A57-A496-1CEF71E63091 Q42010237-AF5DB622-BB98-433F-A4EF-48AA23855467 Q49187990-1C7BB090-BBF1-4C8C-8ADE-4EA1A9CF0EB6 Q55415533-0D3BDA53-31F2-4D27-A75D-D4ADE16194B8 Q56893551-AEE7A6FC-E1DA-4E6C-A09A-50EA48061DC5

P2860

Mucosal delivery of human papillomavirus pseudovirus-encapsidated plasmids improves the potency of DNA vaccination.

http://www.wikidata.org/entity/Q34075698

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Mucosal delivery of human papi ...... he potency of DNA vaccination.

@ast

Mucosal delivery of human papi ...... he potency of DNA vaccination.

@en

Mucosal delivery of human papi ...... he potency of DNA vaccination.

@nl

type

label

Mucosal delivery of human papi ...... he potency of DNA vaccination.

@ast

Mucosal delivery of human papi ...... he potency of DNA vaccination.

@en

Mucosal delivery of human papi ...... he potency of DNA vaccination.

@nl

prefLabel

Mucosal delivery of human papi ...... he potency of DNA vaccination.

@ast

Mucosal delivery of human papi ...... he potency of DNA vaccination.

@en

Mucosal delivery of human papi ...... he potency of DNA vaccination.

@nl

P1433

Q34075698-B5B1D16F-6712-4E11-A8A0-9F0B1427E911

P1476

Q34075698-85DDDB5D-5071-44BB-A44D-6F8F5B80AA93

P2093

Q34075698-49EA5A14-C891-47D7-8DB5-A25273F6B89B

Q34075698-4E8AFF12-106E-4CB1-9A45-1E07AA8AC232

Q34075698-4ED6C1B7-FB8C-445D-A995-5E7D79F63C8D

Q34075698-530ED2C3-CD77-44E5-AAA9-600C23E3A001

Q34075698-6858A73E-517D-41E5-94A7-EFA207AFDB42

Q34075698-9CACC343-017F-443D-8EE1-A21975743010

Q34075698-BD21CEA6-DAA3-497B-A6C2-E3F4EE4257D6

Q34075698-CA8E597D-15AE-4848-8A9B-779F7D54BD26

Q34075698-DF6C8BFC-F5DA-4EEA-A8C2-C3FEC6DE4DDB

Q34075698-F68B64EF-D448-4FA4-B399-AA10DDA76F93

P2860

Q34075698-00C0CF8C-9DCE-41F7-8B23-E610DF0B4BB9

Q34075698-0B301171-3994-47D5-A502-F4136D114F15

Q34075698-1610D2D4-1658-43B1-8776-E1DB0C7B5CEB

Q34075698-1F62A9FF-CE0A-47FD-A11D-1873AE650103

Q34075698-203CBDBA-1DE2-4081-97EA-9C78D36458CC

Q34075698-227240F1-9BDD-4ADA-9DA3-57BFA86205B9

Q34075698-240318FB-B887-4799-AD7B-007C080B9206

Q34075698-2CB04F78-5314-4057-81E4-FE9AC10BEEA2

Q34075698-2DE8A0FF-61C1-4802-B1EC-C03B22ACCF37

Q34075698-3C2959D0-687E-4227-8DE9-141677D172A8

P2888

Q34075698-627FB5B0-45EB-4B9A-8788-A1B76274018C

P304

Q34075698-EBDFC3D3-5A6D-4E8B-A7FA-B479F1A43DF7

P31

Q34075698-78847AFD-7E26-4B69-A7B4-640B6A4A6A84

P356

Q34075698-BF24EE70-2788-49F0-8B68-13BA2223179A

P433

Q34075698-62891C61-D4ED-4C47-9ED2-F09D81256820

P478

Q34075698-3CEE89EC-944D-463B-BA36-98AD11F676BB

P50

Q34075698-33138592-9073-4F38-8E5C-8CDF201F4708

P577

Q34075698-F3C96B06-47D0-4592-8768-5F5E950F438E

P5875

Q34075698-8A57B6A3-5579-4AF2-A197-0AC380126A31

P6179

Q34075698-003D5D28-03A4-4C43-B5F2-D7187EBD8BFB

P698

Q34075698-9F6A2693-6DC6-4A96-ADE4-59D0D5A0DC80

P932

Q34075698-2FDED671-1264-4118-A527-9F228BE10778

P356

P1433

Mucosal Immunology

P1476

Mucosal delivery of human papi ...... he potency of DNA vaccination.

@en

P2093

B S Graham

http://www.w3.org/2001/XMLSchema#string

D LaVigne

http://www.w3.org/2001/XMLSchema#string

J N Roberts

http://www.w3.org/2001/XMLSchema#string

J Nicewonger

http://www.w3.org/2001/XMLSchema#string

J T Schiller

http://www.w3.org/2001/XMLSchema#string

K S Corbett

http://www.w3.org/2001/XMLSchema#string

M Chen

http://www.w3.org/2001/XMLSchema#string

N Cuburu

http://www.w3.org/2001/XMLSchema#string

R C Kines

http://www.w3.org/2001/XMLSchema#string

T R Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Prophylactic human papillomavirus vaccines

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge

In vitro construction of pseudovirions of human papillomavirus type 16: incorporation of plasmid DNA into reassembled L1/L2 capsids.

Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine

Interleukin-4 diminishes CD8(+) respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo

Maturation of papillomavirus capsids.

Papillomavirus pseudovirus: a novel vaccine to induce mucosal and systemic cytotoxic T-lymphocyte responses.

Disruption of tight junctions by cellulose sulfate facilitates HIV infection: model of microbicide safety

A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates

P2888

P304

475-486

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MI.2010.31

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Christopher B. Buck

P577

2010-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44680134

http://www.w3.org/2001/XMLSchema#string

P6179

1022505368

http://www.w3.org/2001/XMLSchema#string

P698

20555315

http://www.w3.org/2001/XMLSchema#string

P932

2924464

http://www.w3.org/2001/XMLSchema#string